. . . "3-8 hours"@en . . "144-82-1"@en . . . . "Rapidly absorbed."@en . . . "Sulfamethizolum"@en . . "Sulfametizol"@en . . "Sulfamethylthiadiazole"@en . "approved"@en . . . . . . . "A sulfathiazole antibacterial agent. [PubChem]"@en . . . . . . . "Sulfamethizol"@en . . . . "Sulfamethizole"@en . . . "For the treatment of urinary tract infection"@en . . . "98-99%"@en . . "Sulfamethizole is a competitive inhibitor of bacterial enzyme dihydropteroate synthetase. The normal para-aminobenzoic acid (PABA) substrate is prevented from binding. The inhibited reaction is necessary in these organisms for the synthesis of folic acid."@en . . . . . . . "Sulfamethizole"@en . . . " "@en . "Enteric bacteria and other eubacteria"@en . . . "Rufol"@en . . . . . . . . . . . . . . . . . . "# Ratanajamit C, Skriver MV, Norgaard M, Jepsen P, Schonheyder HC, Sorensen HT: Adverse pregnancy outcome in users of sulfamethizole during pregnancy: a population-based observational study. J Antimicrob Chemother. 2003 Nov;52(5):837-41. Epub 2003 Sep 30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14519675 # Kerrn MB, Frimodt-Moller N, Espersen F: Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model. Antimicrob Agents Chemother. 2003 Mar;47(3):1002-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12604534 # Watanabe H, Hastings JW: Inhibition of bioluminescence in Photobacterium phosphoreum by sulfamethizole and its stimulation by thymine. Biochim Biophys Acta. 1990 Jun 26;1017(3):229-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2372557"@en . . "Sulfam\u00E9thizol"@en . . .